Mitodicure’s mission is to cure Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), for which there is no effective treatment. With the founders' decades of experience in drug discovery, we are developing a small molecule drug for this frequent and debilitating disease. Patients with Long COVID and Fibromyalgia could also benefit from our medication.
Follow us: https://x.com/mitodicure
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://mitodicure.com
- Keywords
- ME/CFS, Long COVID, Fibromyalgia.
Mitodicure Gmbh Questions
Mitodicure Gmbh's website is https://mitodicure.com
Mitodicure Gmbh's LinkedIn profile is https://www.linkedin.com/company/mitodicure
Mitodicure Gmbh has
3 employees.
View email and phone details for 3
employees at Mitodicure Gmbh.
Mitodicure Gmbh's industry is
Biotechnology Research
Mitodicure Gmbh's top competitors are
Collaborationlab,
Berlin Cures Holding Ag,
Apontis Pharma Deutschland Gmbh & Co. Kg,
Aprofol Ag,
Streasure4health,
22 Zentury Gmbh,
Lykos Capital Gmbh,
Benfovir Ag,
Not Recovered Belgium,
Acta Lab.
Mitodicure Gmbh's categories are Biotechnology Research
Mitodicure Gmbh's founding year is 2022
